Article reviewed: Serum leptin and vascular risk factors in obstructive sleep apnea

Sleep Medicine

Volumn 2, Issue 2, 2001, Pages 161-163

  Sanders, M H ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; BODY MASS; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE MARKER; FEMALE; HUMAN; MALE; NOTE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RISK FACTOR; SKINFOLD THICKNESS; SLEEP APNEA SYNDROME; SYSTOLIC BLOOD PRESSURE;

EID: 0035088674     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1389-9457(01)00074-0     Document Type: Note

References (6)

1. Leptin prevents respiratory depression in obesity
2. Leptin attenuates respiratory complications associated with the obese phenotype
3. Changes in intraabdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy
4. Relationship between muscle sympathetic nerve activity and plasma leptin concentration
5. Recombinant leptin for weight loss in obese and lean adults: A randomized, controlled, dose escalated trial
6. Self-reported use of CPAP and benefits of CPAP therapy. A patient survey